Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics

The COVID-19 pandemic has emerged as a public health crisis and has placed a significant burden on healthcare systems. Patients with underlying metabolic dysfunction, such as type 2 diabetes mellitus and obesity, are at a higher risk for COVID-19 complications, including multi-organ dysfunction, sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Batabyal, Rachael, Freishtat, Nathaniel, Hill, Elaise, Rehman, Muhammad, Freishtat, Robert, Koutroulis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961323/
https://www.ncbi.nlm.nih.gov/pubmed/33727631
http://dx.doi.org/10.1038/s41366-021-00804-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961323/
https://www.ncbi.nlm.nih.gov/pubmed/33727631
http://dx.doi.org/10.1038/s41366-021-00804-7

Ejemplares similares